Is	is	O	O
phenytoin	phenytoin	S_chemicals	O
administration	administration	O	O
safe	safe	O	O
in	in	O	O
a	a	O	O
hypothermic	hypothermic	O	O
child?A	child?a	O	O
male	male	O	O
neonate	neonate	O	O
with	with	O	O
a	a	O	O
Chiari	chiari	O	O
malformation	malformation	O	O
and	and	O	O
a	a	O	O
leaking	leaking	O	O
myelomeningocoele	myelomeningocoele	O	O
underwent	underwent	O	O
ventriculoperitoneal	ventriculoperitoneal	O	O
shunt	shunt	O	O
insertion	insertion	O	O
followed	followed	O	O
by	by	O	O
repair	repair	O	O
of	of	O	O
myelomeningocoele	myelomeningocoele	O	O
.	.	O	O

During	during	O	O
anaesthesia	anaesthesia	O	O
and	and	O	O
surgery	surgery	O	O
,	,	O	O
he	he	O	O
inadvertently	inadvertently	O	O
became	became	O	O
moderately	moderately	O	O
hypothermic	hypothermic	O	O
.	.	O	O

Intravenous	intravenous	O	O
phenytoin	phenytoin	S_chemicals	O
was	was	O	O
administered	administered	O	O
during	during	O	O
the	the	O	O
later	later	O	O
part	part	O	O
of	of	O	O
the	the	O	O
surgery	surgery	O	O
for	for	O	O
seizure	seizure	O	S_disease
prophylaxis	prophylaxis	O	O
.	.	O	O

Following	following	O	O
phenytoin	phenytoin	S_chemicals	O
administration	administration	O	O
,	,	O	O
the	the	O	O
patient	patient	O	O
developed	developed	O	O
acute	acute	O	O
severe	severe	O	O
bradycardia	bradycardia	O	S_disease
,	,	O	O
refractory	refractory	O	O
to	to	O	O
atropine	atropine	O	O
and	and	O	O
adrenaline	adrenaline	S_chemicals	O
.	.	O	O

The	the	O	O
cardiac	cardiac	B_chemicals	O
depressant	depressant	I_chemicals	O
actions	actions	O	O
of	of	O	O
phenytoin	phenytoin	S_chemicals	O
and	and	O	O
hypothermia	hypothermia	O	S_disease
can	can	O	O
be	be	O	O
additive	additive	O	O
.	.	O	O

Administration	administration	O	O
of	of	O	O
phenytoin	phenytoin	S_chemicals	O
in	in	O	O
the	the	O	O
presence	presence	O	O
of	of	O	O
hypothermia	hypothermia	O	S_disease
may	may	O	O
lead	lead	O	O
to	to	O	O
an	an	O	O
adverse	adverse	O	B_disease
cardiac	cardiac	O	B_disease
event	event	O	I_disease
in	in	O	O
children	children	O	O
.	.	O	O

As	as	O	O
phenytoin	phenytoin	S_chemicals	O
is	is	O	O
a	a	O	O
commonly	commonly	O	O
used	used	O	O
drug	drug	S_chemicals	O
,	,	O	O
clinicians	clinicians	O	O
need	need	O	O
to	to	O	O
be	be	O	O
aware	aware	O	O
of	of	O	O
this	this	O	O
interaction	interaction	O	O
.	.	O	O

